pharmaphorum1d
FDA fast-tracks Sanofi's experimental chlamydia vaccine
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
Zacks Investment Research on MSN1d
Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag
Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...
PharmExec5h
FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.
En Pareja on MSN3d
SIGNS a Guy Might Have Chlamydia and How to Get Rid of It
Living a healthy life means knowing the symptoms of chlamydia and taking the necessary precautions under a doctor's guidance.
MPR1d
Chlamydia Vaccine Candidate Gets Fast Track Status
The Food and Drug Administration (FDA) has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
Medical Dialogues1d
Sanofi gets USFDA fast track designation for Chlamydia vaccine candidate
Paris: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate ...
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...
FDA authorizes Visby Medical’s home test for three STDs
The U.S. Food and Drug Administration (FDA) has granted marketing authorization to Visby Medical for its Women’s Sexual Health Test, the first home diagnostic test for chlamydia, gonorrhea, and ...
European Medical Journal4h
Sanofi’s chlamydia vaccine fast-tracked by FDA
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
Pharmabiz9h
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection: Paris Friday, March 28, 2025, 12:00 Hrs [IST] The US Food and Drug ...
GlobalData on MSN2d
FDA fast tracks Sanofi’s mRNA vaccine for chlamydia
Sanofi will soon commence a Phase I/II trial with its vaccine candidate to start generating immunogenicity data.
Contract Pharma2d
Sanofi’s Chlamydia Vaccine Candidate Granted Fast Track Designation by FDA
The FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.